/
COMPANY OVERVIEW Cibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant s seed. Plant traits, or characteristics, influence how a resulting plant functions and/or interacts with its environment.
The business is unprofitable at the operating level (-2680.10% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 14.6% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$51M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$4M
▼ -14.6% YoY
Net Income (TTM)
-$101M
▲ +49.4% YoY
Op. Margin
-1588.38%
▲ +3382.7pp YoY
ROIC
-68.43%
▲ +7.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$51M
▲ +13.1% YoY
Op. Cash Flow (TTM)
-$50M
▲ +12.8% YoY
Net Debt
$2M
Cash & Equiv.
$30M
5Y CAGR: -31.3%
Continue Research